EconPapers    
Economics at your fingertips  
 

Knowledge, Attitude, and Acceptance of Sinopharm and AstraZeneca’s COVID-19 Vaccines among Egyptian Population: A Cross-Sectional Study

Marian S. Boshra, Marwa O. Elgendy, Lamiaa N Abdelaty, Mahmoud Tammam, Abdullah S. Alanazi (), Abdulaziz Ibrahim Alzarea, Saud Alsahali and Rania M. Sarhan
Additional contact information
Marian S. Boshra: Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt
Marwa O. Elgendy: Clinical Pharmacy Department, Beni-Suef University Hospitals, Faculty of Medicine, Beni-Suef University, Beni-Suef 62511, Egypt
Lamiaa N Abdelaty: Department of Clinical Pharmacy, Faculty of Pharmacy, October 6 University, Giza 12525, Egypt
Mahmoud Tammam: IQVIA, Cairo 10245, Egypt
Abdullah S. Alanazi: Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia
Abdulaziz Ibrahim Alzarea: Clinical Pharmacy Department, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia
Saud Alsahali: Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia
Rania M. Sarhan: Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt

IJERPH, 2022, vol. 19, issue 24, 1-12

Abstract: Background: This study aimed to evaluate the Egyptian population’s preference and awareness related to available COVID-19 vaccines and to determine different factors that can affect beliefs concerning these vaccines. Methods: A cross-sectional web-based study was carried out among the general population in Egypt. Data collection was conducted via an online questionnaire. Results: About 426 subjects participated in the survey. Vaccine preference is nearly equally even (50%) among all respondents. There was no significant difference in vaccine preference according to age, gender, residence, educational level, or social status. About 50% of public respondents mentioned that both AstraZeneca and Sinopharm vaccines do not offer protection against new variant COVID-19 strains. Healthcare workers are the lowest respondents to agree that vaccines offer protection against new COVID-19 variants (10.9%) compared to unemployed respondents (20.3%) and other professions (68.8%) with a statistically significant difference ( p < 0.005). Safety of vaccine administration among children below 18 showed statistical differences for gender and educational level predictors. Conclusions: Most of the study population has satisfying knowledge about the COVID-19 vaccine. Continuous awareness campaigns must be carried out so that the people’s background is updated with any new information that would help in raising the trust in vaccination.

Keywords: COVID-19; vaccines; awareness; Sinopharm; AstraZeneca (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/24/16803/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/24/16803/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:24:p:16803-:d:1003390

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().

 
Page updated 2025-03-19
Handle: RePEc:gam:jijerp:v:19:y:2022:i:24:p:16803-:d:1003390